HC Wainwright & Co. Reiterates Buy on Imunon, Maintains $14 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Emily Bodnar has reiterated a Buy rating on Imunon (NASDAQ:IMNN) and maintained a $14 price target.
August 15, 2024 | 11:25 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Emily Bodnar has reiterated a Buy rating on Imunon and maintained a $14 price target.
The reiteration of a Buy rating and the maintenance of a $14 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100